James Hazel is the Research Programme Manager for the Access to Medicine Index, leading the programme’s dedicated research team.
James has extensive experience applying quantitative and qualitative research methodologies to analyse the ethical, legal, and social implications of complex issues, including international genomics research initiatives and the direct-to-consumer genetic testing industry. Prior to joining the Foundation, he served as a postdoctoral research fellow in the Department of Health Policy at Vanderbilt University Medical Center in the USA, where he approached issues of access primarily through the lens of a biomedical researcher.
A molecular biologist and lawyer by training, he holds a law degree (J.D.) from Vanderbilt University Law School and a Ph.D. in Molecular Biology from the University of Wyoming, where his doctoral research focused on the mitotic spindle, the target of many chemotherapeutic cancer drugs.